Goeltz II Robert C. 4
4 · Arcus Biosciences, Inc. · Filed Jan 2, 2026
Insider Transaction Report
Form 4
Goeltz II Robert C.
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-12-31$23.38/sh−6,552$153,186→ 67,924 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.